₹1,287.60
−0.73%NSE close, 16 Nov 2026
−16.13%
Zota Health Care is a small cap company, listed on NSE under the symbol ZOTA. At ₹1,287.60 a share, the market values the whole company at ₹4,459 crore.
In FY26, it reported sales of ₹539 crore and a net loss of ₹74 crore, an operating margin of 3.4%. Over the last three years, sales grew 60.1% a year.
The market values the company at 7.13 times its book value; its return on equity is -18.0% and its borrowings are 0.05 times its equity.
Promoters hold 49.38% of the shares, and have pledged 0.3% of their holding. Foreign institutions hold 6.92%, and domestic institutions, mutual funds among them, 7.30%.
Over the past year the share price has fallen 15.8%, and it is 26.0% below its 52-week high.
₹ crore. Consolidated figures.
Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raised through Qualified Institutional Placement for the quarter ended September 30, 2026
Transcript of Earnings Conference Call on Financial Results for the quarter ended September 30, 2026
Audio Recording Link of Earnings Conference Call on financial results for the quarter and half year ended September 30, 2026
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 46.9 | 49.6 | 56.3 | 67.3 | 72.1 | 97.3 | 104 | 129 | 143 | 163 | 174 | 199 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 43.6 | 51.1 | 57.6 | 68.2 | 78.2 | 94.8 | 99.6 | 123 | 143 | 154 | 185 | 196 |
| Operating profit | 3.3 | −1.5 | −1.3 | −0.9 | −6.1 | 2.5 | 4.0 | 6.3 | −0.4 | 8.7 | −11.6 | 3.1 |
| Operating margin | 7.1% | -3.0% | -2.2% | -1.3% | -8.4% | 2.5% | 3.8% | 4.9% | -0.3% | 5.3% | -6.7% | 1.5% |
| Other income | 0.2 | 0.5 | 0.0 | 0.5 | 0.5 | 1.0 | 0.9 | 1.6 | 1.7 | 3.2 | 2.0 | 4.9 |
| Interest | 1.1 | 1.7 | 2.9 | 2.9 | 1.6 | 3.5 | 3.2 | 3.8 | 5.0 | 5.3 | 6.4 | 6.4 |
| Depreciation | 5.1 | 6.8 | 8.0 | 9.5 | 11.4 | 14.3 | 14.7 | 18.5 | 22.3 | 27.0 | 27.8 | 28.7 |
| Profit before tax | −2.7 | −9.5 | −12.2 | −12.7 | −18.5 | −14.3 | −13.1 | −14.4 | −26.0 | −26.4 | −43.7 | −27.1 |
| Tax | 0.2 | −2.6 | 0.6 | −0.5 | 0.5 | −1.4 | 0.7 | 1.8 | 3.7 | −12.0 | 0.3 | −1.1 |
| Net profit | −2.9 | −6.9 | −12.7 | −12.1 | −18.7 | −12.9 | −14.3 | −16.0 | −29.5 | −14.2 | −43.6 | −25.6 |
| EPS (₹) | -1.14 | -2.68 | -4.80 | -4.57 | -6.80 | -4.57 | -4.92 | -5.26 | -9.44 | -4.13 | -12.58 | -7.39 |
₹ crore, financial years to March.
| Line | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Sales | 95.1 | 107 | 131 | 180 | 293 | 539 |
| Expenses | 90.6 | 106 | 116 | 173 | 299 | 520 |
| Operating profit | 4.5 | 0.6 | 14.8 | 7.6 | −5.7 | 18.5 |
| Operating margin | 4.8% | 0.6% | 11.3% | 4.2% | -2.0% | 3.4% |
| Other income | 1.5 | 1.3 | 1.6 | 1.2 | 2.1 | 7.4 |
| Interest | 0.1 | 0.1 | 0.3 | 4.8 | 10.8 | 17.4 |
| Depreciation | 2.1 | 3.2 | 3.7 | 20.1 | 43.2 | 82.5 |
| Profit before tax | 3.9 | −0.4 | 12.4 | −16.2 | −57.6 | −79.8 |
| Tax | 1.1 | −0.2 | 3.5 | −1.8 | −0.9 | −5.8 |
| Net profit | 2.7 | −0.2 | 8.9 | −14.4 | −56.4 | −73.9 |
| EPS (₹) | 1.12 | -0.09 | 3.58 | -5.59 | -20.68 | -22.46 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 13.3 | −50.0 | −84.4 | −51.1 |
| From investing | −26.7 | −92.2 | −314 | 68.3 |
| From financing | 14.3 | 145 | 490 | −35.3 |
| Spent on fixed assets | −3.3 | 0 | 0 | −22.3 |
| Free cash flow | 10.1 | −50.0 | −84.4 | −73.4 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net margin | 2.9% | -0.2% | 6.8% | -8.0% | -19.3% | -13.7% |
| Operating margin | 4.8% | 0.6% | 11.3% | 4.2% | -2.0% | 3.4% |
| Return on equity | – | – | – | -15.9% | -25.2% | -10.7% |
| Return on capital employed | – | – | – | -10.9% | -20.4% | -8.7% |
| Return on assets | – | – | – | -6.3% | -12.8% | -6.5% |
| Debt to equity | – | – | – | 0.16 | 0.03 | 0.04 |
| Interest coverage | 56.10 | -2.40 | 39.80 | -2.40 | -4.30 | -3.60 |
| Debt to assets | – | – | – | 0.06 | 0.01 | 0.03 |
| Current ratio | – | – | – | 1.51 | 1.83 | 1.93 |
| Quick ratio | – | – | – | 0.79 | 0.78 | 1.11 |
| Cash ratio | – | – | – | 0.01 | 0.02 | 0.03 |
| Asset turnover | – | – | – | 0.79 | 0.67 | 0.48 |
| Fixed asset turnover | – | – | – | 7.66 | 5.23 | 3.84 |
| Inventory turnover | – | – | – | 1.80 | 1.30 | 1.10 |
| Receivables turnover | – | – | – | 6.60 | 7.20 | 7.30 |
| Gross margin | – | – | – | 46.4% | 53.1% | 60.3% |
| Cash from operations to profit | – | – | 150.0% | – | – | – |
| Effective tax rate | 29.0% | – | 28.4% | – | – | – |
ZOTA: Zota Health Care Limited has informed the Exchange regarding a press release dated October 28, 2026, titled "Zota Health Care Limited Reports Healthy Q2FY27 Performance, Amid Planned Moderation in Store Expansion
The Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026
The Intimation of Schedule of Earnings Conference Call on Q2FY27 Results
Significant increase in volume has been observed in Zota Health Care LImited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to…
Clarification regarding Increase in Volume
Significant increase in volume has been observed in Zota Health Care LImited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to…
Davaindia Stores Update for Q2FY27
Acquisition of 39,228 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.
Acquisition of 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue
Acquisition of 20,20,000 equity shares of M/s Curexis Ventures Private Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.